Search PubMed⌕ Search

Biomedical subjects

M Klockars

Publications and source records attributed to M Klockars.

At least 109 records · Page 6Linked to original sources
PubMed1978

Clearance ratios of amylase and isoamylase to creatinine in renal disease.

Amylase to creatinine clearance ratios were measured in 66 patients with a variety of moderate and severe renal diseases including 10 patients with renal transplants, and in 13 healthy controls. Only in patients with severe renal insufficiency (serum creatinine level above 660 micronmoles/1) were the amylase to creatinine ratios significantly raised. The ratios correlated neither with the type of renal disease, i.e. glomerular or tubulointerstitial, nor with the degree of proteinuria. Patients with renal transplants did not differ from other patients. Clearance ratios of pancreatic and salivary isoamylase to creatinine changed in parallel to that of total amylase. The results suggest that in severe renal failure the loss of nephrons results in decreased fractional reabsorption of amylase in the tubules.

Amylases↗
PubMed1977

Immunohistochemical demonstration of lysozyme in the lymph nodes and Kveim reaction papules in sarcoidosis.

Lysozyme (LZM) was demonstrated by an immunoperoxidase method in some but not all epitheloid-cell granulomas, free macrophages and giant cells in the lymph nodes and Kveim reaction papules of patients with sarcoidosis. In inactive disease, LZM staining was weak or absent in fibrotic lymph nodes. The pattern of LZM staining in Kveim reaction papules was similar to that seen in the "active" sarcoid lymph nodes. The presence of LZM in sarcoid tissue explains the high concentration of serum LZM in patients with active sarcoidosis and the extent of LZM distribution in tissues is probably an index of disease activity.

Epithelial Cells↗
PubMed1977

Lymphocyte subpopulations in rheumatoid synovial tissue.

Synovial tissue obtained at synovectomy of the knee joint in 21 patients with rheumatoid arthritis contained a significantly lower proportion of T lymphocytes as measured by spontaneous rosette formation with nonsensitized sheep red blood cells than did synovial fluid or blood from the same patients. There was on concomitant increase in synovial tissue lymphocytes with B-cell markers such as surface immunoglobulin or Fc fragment receptors. Removal of lymphocyte receptors with trypsin followed by culture to allow new receptors to form, led to an increase in rosette forming cells, suggesting that part of the synovial cells without B- or T-cell markers may be T lymphocytes with blocked receptors.

Arthritis, Rheumatoid↗
PubMed1977

Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.

Lysozyme (LZM) was identified in ulcerative colitis in granulocytes, monocytes, and macrophages of the intestinal lamina propria. In contrast with findings in normal colon or rectum, in ulcerative colitis LZM was also detected in some mucosal crypt cells and metaplastic Paneth cells. In both ulcerative colitis and Crohn's disease LZM was present in inflammatory cells of crypt abscesses. In Crohn's disease intense LZM staining was seen in epitheloid cell granulomas. The present observations permit one explanation for the raised concentration of serum-LZM in patients with ulcerative colitis and Crohn's disease.

Colitis, Ulcerative↗
PubMed1977

Ontogeny of human lysozyme. Distribution in fetal tissues.

Using the immunoperoxidase method, major changes in the distribution of lysozyme (LZM) were found to occur during fetal development. At 10 weeks of gestation LZM was detected for the first time in the proximal tubules of the kidney. This generally coincides with the reported appearance of LZM in fetal blood and amniotic fluid. The enzyme was observed in lung macrophages and in mononuclear cells of the lamina propria of the small intestine in fetuses 12 and 16 weeks old, respectively. At about 18--20 weeks, LZM-positive mononuclear cells were detected in other tissues tested, such as liver, spleen and thymus. Paneth cells were found to be specifically stained at about 20 weeks of gestation. The timing of the appearance of LZM in the various tissues is discussed in relation to the functional maturation of each organ and the ontogeny of this enzyme in other species.

Amniotic Fluid↗
PubMed1977

Serum lysozyme, antinuclear factors and antibody to native DNA.

This work was done in order to investigate the previously reported antinuclear property of lysozyme (LZM). Addition of human or hen egg white lysozyme (hLZM or eLZM) to normal serum and to 11 sera with different types of antinuclear factors (ANF) produced no consistent changes in ANF titre or type. Likewise, absorption of LZM from the sera with bentonite failed to influence ANF titre and, finally, hLZM and eLZM were incapable of binding native DNA (nDNA). Elevated serum lysozyme levels in rheumatic diseases are therefore unlikely to produce false-positive results in tests for antinuclear antibodies.

Antibodies↗
PubMed1977

Serum lysozyme in sarcoidosis. Evaluation of its usefulness in determination of disease activity.

Serum lysozyme (LZM) determinations were done in 84 patients with clinically proven sarcoidosis. All patients were normocalaemic and had a normal renal function. An increased LZM activity was demonstrated in patients with pulmonary stage I and stage II disease, as well as in patients with extrapulmonary lesions. Treatment with corticosteroids rapidly normalized the LZM activity. A normal LZM activity was found in patients with cured sarcoidosis. The serum LZM activity seems to reflect the total mass of biologically active granulomas and is of great value in determining the activity of the disease. The dosage of corticosteroids can probably be administered according to the actual LZM level. Increasing LZM activity after stopping treatment may indicate progressive and uncured disease. Normal LZM activity in patients with even large pulmonary lesions seems to indicate inactive disease and unresponsiveness to treatment.

Adrenal Cortex Hormones↗
PubMed1976

Lysozyme activity in cerebrospinal fluid.

The concentration of lysozyme (LZM) in cerebrospinal fluid (CSF) has been studied in 148 patients to evaluate its possible significance in the differential diagnosis of various diseases affecting the central nervous system (CNS). In the control group only 3 of 45 patients had detectable LZM in their CSF, the highest value being 1.3 mug/ml. The diabetic and epileptic groups did not differ from the control group. Of 8 patients with primary intracranial tumours, 4 had raised CSF-LZM levels. Twenty of 23 uraemic patients had elevated CSF-LZM, the highest value being 3.3 mug/ml. The highest values were found in patients with bacterial meningitis, tuberculous meningitis and leptomeningitis due to Aspergillus. A positive correlation was found between CSF-LZM and protein concentrations. The measurement of LZM may be of value in the diagnosis of inflammatory processes affecting the CNS and in the diagnosis of certain intracranial tumours.

Aged↗
PubMed1976

Stimulation of phagocytosis by human lysozyme.

Human lysozyme in physiologic concentrations (10--400 mug/ml) significantly (p less than 0.001) stimulates the phagocytosis of yeast cells by human polymorphonuclear leukocytes. This stimulating effect was observed even in the absence of serum factors. Hen egg white lysozyme or protamine sulfate had no effect on phagocytosis. The stimulating effect of human lysozyme was not the result of opsonization but was apparently related to the effects on constituent membranes of the phagocytic cells.

Cell Membrane↗
PubMed1976

Extracorporeal irradiation of thoracic duct lymph as immunosuppressive treatment in rheumatoid arthritis.

Thoracic duct drainage and re-infusion of the irradiated lymph was carried out as immunosuppressive treatment in 2 patients with progressive, therapy-resistant rheumatoid arthritis. In both patients, a marked clinical improvement was achieved even during the first days of treatment. A reduced number of T cells in the blood was seen 3 days after onset of drainage, whereas no significant change in the number of B cells was observed. No recirculation of the infused cells could be detected, nor was the radiation removal of T cells accompanied by rapid proliferation of "new" T cells. As clinical improvement and reduction in T cells occurred simultaneously, there is probably a connection between these two events. The beneficial clinical response and the achievement of T cell suppression by thoracic duct drainage--the result of irradiation and re-infusion of irradiated lymph--encourage further clinical trials with this type of treatment in severe therapy-resistant rheumatoid arthritis.

Arthritis, Rheumatoid↗
PubMed1975

Tissue distribution of lysozyme in man.

The distribution of lysozyme (LZM) in normal human tissues was determined with the use of the immunoglobulin-enzyme (peroxidase) bridge method. LZM was detected in the following cells and tissues: secretory cells of the lacrimal gland, ductal epithelial cells of the parotid gland and the serous parts of the mixed sublingual glands, the esophageal submucosal glands, bronchial serous submucosal glands, gastric and pyloric glands, Brunner's glands of the duodenum, the Paneth cells of the small intestine, Kupffer cells of the liver and renal proximal tubular cells. In addition, LZM was also found in the mononuclear or polymorphonuclear cells of the placenta, lung, lamina propria of the small intestine, lymph nodes and spleen. This distribution of LZM is discussed in relation to its possible physiologic role in human tissues and particularly to its known antibacterial properties.

Fluorescent Antibody Technique↗
PubMed1975

Lysosomes.

Explore the source record for details and available documents.

Arthritis, Rheumatoid↗